title: N-acetylcysteine prevents electrical remodeling and attenuates cellular hypertrophy in epicardial myocytes of rats with ascending aortic stenosis.
abstract: Pressure overload is associated with cardiac hypertrophy and electrical remodeling. Here, we investigate the effects of the antioxidant N-acetylcysteine (NAC) on the cellular cardiac electrophysiology of female Sprague-Dawley rats with ascending aortic stenosis (AS). Rats were treated with NAC (1 g/kg body weight) or control solution 1 week before the intervention and in the week following AS or sham operation. Seven days after the operation, blood pressure and left ventricular pressure were measured before the heart was excised. Single cells were isolated from epicardial and endocardial layers of the left ventricular free wall and investigated using the whole-cell patch-clamp technique. Systolic blood pressure and left ventricular peak pressure were not significantly altered in the NAC group. NAC reduced the increase (p < 0.001) in the relative left ventricular weight (p < 0.05) as well as the increase (p < 0.001) in cell capacitance in epicardial (p < 0.05), but not in endocardial myocytes of AS animals. The L-type Ca(2+) current (I                         (CaL)) was significantly increased by AS in epicardial (+19 % at 0 mV, p < 0.01) but not in endocardial myocytes. NAC completely prevented this increase in I                         (CaL) (p < 0.01). The current density of the transient outward K(+) current (I                         (to)) was not affected by AS or NAC. Action potential duration to 90 % repolarization was significantly prolonged in epicardial (p < 0.01) as well as in endocardial (p < 0.001) cells of AS animals. NAC prevented the AP prolongation in epicardial myocytes only (p < 0.05). We conclude that reducing oxidative stress in pressure overload can prevent electrical remodeling and ameliorate hypertrophy in epicardial but not in endocardial myocytes.
authors.affiliation: Institut für Zelluläre und Molekulare Physiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstraße 6, Erlangen, Germany.
authors.forename: Wibke U
authors.initials: WU
authors.lastname: Foltz
authors.forename: Michael
authors.initials: M
authors.lastname: Wagner
authors.forename: Elena
authors.initials: E
authors.lastname: Rudakova
authors.forename: Tilmann
authors.initials: T
authors.lastname: Volk
mesh_terms: D000111:Acetylcysteine / Q000627:therapeutic use*; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001011:Aorta; D001024:Aortic Valve Stenosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D020746:Calcium Channels, L-Type / Q000502:physiology; D006332:Cardiomegaly / Q000188:drug therapy*; D004699:Endocardium / Q000473:pathology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D032383:Myocytes, Cardiac / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020257:Ventricular Remodeling
chemical_list: D000975:Antioxidants; D020746:Calcium Channels, L-Type; D002118:Calcium; D000111:Acetylcysteine